Microarray synthesis and assembly of gene-length polynucleotides
US-9023601-B2 · May 5, 2015 · US
US11492727B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11492727-B2 |
| Application number | US-202016802423-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 26, 2020 |
| Priority date | Feb 26, 2019 |
| Publication date | Nov 8, 2022 |
| Grant date | Nov 8, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are methods and compositions relating to glucagon-like peptide-1 receptor (GLP1R) libraries having nucleic acids encoding for a scaffold comprising a GLP1R binding domain. Libraries described herein include variegated libraries comprising nucleic acids each encoding for a predetermined variant of at least one predetermined reference nucleic acid sequence. Further described herein are protein libraries generated when the nucleic acid libraries are translated. Further described herein are cell libraries expressing variegated nucleic acid libraries described herein.
Opening claim text (preview).
What is claimed is: 1. A nucleic acid library, comprising: a plurality of nucleic acids, wherein each of the nucleic acids encodes for a sequence that when translated encodes for a GLP1R binding immunoglobulin, wherein the GLP1R binding immunoglobulin comprises a variant of a GLP1R binding domain, wherein the GLP1R binding domain is a ligand for the GLP1R, and wherein the nucleic acid library comprises at least 10,000 variant immunoglobulin heavy chains and at least 10,000 variant immunoglobulin light chains, wherein the variant immunoglobulin heavy chain when translated comprises at least 90% sequence identity to SEQ ID NO: 2303, 2304, 2305, 2306, 2307, 2308, 2309, 2317, 2318, 2319, 2320, or 2321, wherein the variant immunoglobulin light chain when translated comprises at least 90% sequence identity to SEQ ID NO: 2310, 2311, 2312, 2313, 2314, 2315, or 2316. 2. The nucleic acid library of claim 1 , wherein the nucleic acid library comprises at least 50,000 variant immunoglobulin heavy chains and at least 50,000 variant immunoglobulin light chains. 3. The nucleic acid library of claim 1 , wherein the nucleic acid library comprises at least 10 5 non-identical nucleic acids. 4. The nucleic acid library of claim 1 , wherein the nucleic acid library comprises at least 100,000 variant immunoglobulin heavy chains and at least 100,000 variant immunoglobulin light chains.
comprising antibodies · CPC title
containing an intein ("protein splicing")domain · CPC title
containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered · CPC title
Complete light chain, i.e. VL + CL · CPC title
Complete heavy chain or Fd fragment, i.e. VH + CH1 · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.